Role of Cost and Management Accountant in Implementation of Six Sigma in Pharmaceuticals Industry — An Overview

The Management Accountant, Vol 45(11), 2010

Posted: 17 Jun 2019

See all articles by Arindam Banerjee

Arindam Banerjee

J.D.Birla Institute (Department of Management)

Date Written: November 1, 2010

Abstract

This paper examines the challenges of competition and opportunities being faced by the Indian pharmaceutical industry in the present competitive global market. The major challenges are the new Patent Law that came into existence from 1st January 2005, insufficient investment in research and development, low FDI inflow in the pharma sector, tough market competition from leading multinational companies’ front, etc. In spite of these various types of challenges, the industry is contributing well in terms of the total volume of production, export and international market share. The major three components of pharmaceutical products are herbal products, formulation drugs, and bulk drugs, including fine chemicals. It also intends to highlight the role to be played by a Cost and Management Accountant in facing the present day’s challenges by the industry.

Suggested Citation

Banerjee, Arindam, Role of Cost and Management Accountant in Implementation of Six Sigma in Pharmaceuticals Industry — An Overview (November 1, 2010). The Management Accountant, Vol 45(11), 2010, Available at SSRN: https://ssrn.com/abstract=3400840

Arindam Banerjee (Contact Author)

J.D.Birla Institute (Department of Management) ( email )

1,Moira Street ,Kolkata
No Address Available

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Abstract Views
574
PlumX Metrics